ELVAF Stock UPDATES Evolva Holding (ELVAF) 1.3860 09/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Evolva Holding (ELVAF) 1.3860 $ELVAF

Evolva & Cargill Announce Publication Of Stevia Reb M Patent Application
Business Wire - Fri Aug 15, 12:01AM CDT
Evolva Holding SA (SIX:EVE) announced that its patent application (WO 2014122227) on a process to efficiently and sustainably produce next-generation sweeteners via fermentation, including Rebaudioside M ("Reb M" , has now published. The patent application was originally filed on February 6, 2013.

Global Sweetener Market 2014-2018: Key Vendors are Cargill, Cumberland, Merisant and Tate & Lyle
M2 - Thu Jul 31, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/grf9pd/global_sweetener) has announced the addition of the "Global Sweetener Market 2014-2018" report to their offering. Sweetener is a food additive that imparts a sweet taste to food stuff, which usually contains less food energy. Sweeteners are broadly classified into two main types; natural and artificial sweetener. Natural sweeteners are also called as nutritive, sugar, added sugar or caloric sweetener that contains carbohydrates which is a source of energy. For example: stevia, thaumatin, tagatose, and sorbitol among others. Artificial sweeteners often referred as non-nutritive, low calorie or intense sweeteners, provide little or no energy when consumed. For example: aspartame, saccharin, sucralose, and neotame. The analysts forecast the Global Sweetener market to grow at a CAGR of 4.72 percent over the period 2013-2018. The Global Sweetener market can be segmented on the basis of type, application and geography. Segmentation by application can be divided into four divisions: tabletop, food, beverages and others. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Global Sweetener Market 08. Market Segmentation by Type 09. Market Segmentation by Application 10. Geographical Segmentation 11. Key Leading Countries 12. Buying Criteria 13. Market Growth Drivers 14. Drivers and their Impact 15. Market Challenges 16. Impact of Drivers and Challenges 17. Market Trends 18. Trends and their Impact 19. Vendor Landscape 20. Key Vendor Analysis 21. Other Reports in this Series Companies Mentioned: - Amalgamated Sugar Co. - American Crystal Sugar Co. - Archer Daniels Midland Co. - Beckmann-Kenko GmbH - Cargill Inc. - Celanese Corp. - Cumberland Packaging Corp. - Danisco A/S - Evolva Holding SA - Florida Crystal Corp. - GLG Life Tech Corp. - Galam Ltd. - Herboveda - Hermes Sweetener Ltd. - Imperial Sugar Co. - Inc. - Ingredion Inc. - JK Sucralose Inc. - McNeil Nutritionals LLC - Merisant Co. - Morita Kagaku Kogyo Co. Ltd. - NutraSweet Co. - Pure Circle Ltd. - Roquette Freres - Sunwin Stevia International - Tate & Lyle plc - US Sugar Corp. - Zevia LLC - Zydus Wellness Ltd. For more information visit http://www.researchandmarkets.com/research/gr..._sweetener

Evolva Successfully Places New Shares
Business Wire - Wed Feb 26, 12:01AM CST
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN

Evolva reports preliminary, unaudited financial results for 2013 and announces launch of share placement
Business Wire - Tue Feb 25, 10:31AM CST
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN

Global Zero-calorie Sweetener Market 2014-2018: APAC Region Expected to be the Fastest Growing Market for Zero-Calorie Sweeteners during Forecast Period
M2 - Mon Feb 17, 8:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/5btqnj/global) has announced the addition of the "Global Zero-calorie Sweetener Market 2014-2018" report to their offering. The analysts forecast the Global Zero-calorie Sweetener market to grow at a CAGR of 4.69 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing health-consciousness across the world. The Global Zero-calorie Sweetener market has also been witnessing the rise in consumer income levels in emerging countries. However, the negative criticisms about artificial sweeteners could pose a challenge to the growth of this market. Key vendors dominating this space are Cargill Inc., Cumberland Packaging Corp., Merisant Co., and Tate & Lyle plc. Other vendors mentioned in the report are Archer Daniels Midland Co., Celanese Corp., Evolva Holding SA, Hermes Sweetener Ltd., Ingredion Inc., JK Sucralose Inc., McNeil Nutritionals LLC, PureCircle Ltd., Roquette Group, The NutraSweet Co., and Zydus Wellness Ltd. Commenting on the report, an analyst from the team said: One of the key trends in the Global Zero-calorie Sweetener market is the rising consumer income levels in many emerging countries such as China, India, and Brazil. Ongoing economic development has led to an increase in urbanization and consumer income levels in these countries are also rising, thereby increasing purchasing power. Consumers' increasing income has made it easy for them to afford products based on zero-calorie sweeteners which are priced higher than other food and beverage products. The APAC region is expected to be the fastest growing market for zero-calorie sweeteners during the forecast period. Hence, rising consumer income levels will lead to an increase in the demand for zero-calorie sweeteners products in these countries. According to the report, the growth of the Global Zero-calorie Sweetener market is driven by several factors, including the growing health-consciousness across the world. As zero-calorie sweeteners deliver sweetness without adding calories, they are used by those who are health-conscious. For more information visit http://www.researchandmarkets.com/research/5btqnj/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Evolva Announces Collaboration with L'Oreal
Business Wire - Mon Feb 10, 12:00AM CST
Evolva Holding SA (SIX: EVE) announced that it has signed a collaboration agreement with L'Oreal for the co-development of novel biosynthetic production routes for an undisclosed ingredient with broad applications in the cosmetics industry. Evolva and L'Oreal will apply Evolva's fermentation technology platform to develop and optimise yeast strains for the sustainable, cost-effective production of this strategically important cosmetics ingredient.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Telehealth Trends: A Comprehensive Yearly Insight

Updated Category News Views 346

FAIR Health's Telehealth Tracker: A Milestone Year FAIR Health has reached a significant milestone with its Monthly Telehealth Regional Tracker entering its sixth year. This tracker provides valuable insights into how telehealth usage has evolved, empowering stakeholders to understand trends in healthcare delivery. New Features and Data Insights The latest iteration of...

Continue Reading
Exploring Analog Devices: A $1000 Investment Journey

Updated Category News Views 139

The Growth of Analog Devices Inc (NASDAQ: ADI) Investors have increasingly turned their attention to Analog Devices Inc, a leader in the semiconductor industry. Over the last five years, Analog Devices has consistently outperformed the market, showcasing an annualized return of 16.0%. With a current market capitalization standing at an impressive $119.42 billion, the...

Continue Reading
Celebrating Excellence in Clinical Simulation: Meet the Nominees

Updated Category News Views 110

Highlighting Excellence in Clinical Simulation Awards A Representation of the Best in Simulation Healthcare Education in 2024 Education Management Solutions (EMS), a frontrunner in healthcare simulation and competency management platforms, has proudly announced its nominees for the 16th Annual Excellence in Clinical Simulation Awards. Each year, this noteworthy event...

Continue Reading
Significant Oil Price Drop Benefits Airlines and Cruise Lines

Updated Category News Views 195

Oil Prices Experience a Significant Drop Amid Easing Tensions Oil prices witnessed a noticeable decrease recently, plummeting over 5% during early trading in New York. This shift came as geopolitical tensions in the Middle East appeared to stabilize after an assurance from Israeli Prime Minister Benjamin Netanyahu that Iran’s oil facilities would not be targets in any...

Continue Reading
RxSight, Inc. Faces Legal Challenges: Investors Invited to Join Lawsuit

Updated Category News Views 136

RxSight, Inc. Investors Invited to Participate in Class Action Lawsuit Investors of RxSight, Inc. are becoming aware of significant opportunities to engage in a class action lawsuit. This legal action is being initiated by Bronstein, Gewirtz & Grossman, LLC, a law firm with a national reputation for advocating on behalf of investors. They are notifying shareholders that...

Continue Reading